Immunic (IMUX) Retained Earnings (2013 - 2026)

Immunic has disclosed Retained Earnings across 14 years of filings, most recently posting $3.1 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at $3.1 million, up 100.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 100.57% YoY), and the FY2025 annual result was $2.6 million, up 100.52% from the prior year.
• Retained Earnings came in at $3.1 million for Q1 2026 at Immunic, up from $2.6 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $4.3 million in Q1 2024 to a low of -$589.3 million in Q3 2025.
• The 5-year median for Retained Earnings is -$342.6 million (2023), against an average of -$277.1 million.
• Across the five-year window, Retained Earnings surged 101.54% in 2022 and slumped 55438.03% in 2023, its largest moves.
• Immunic's Retained Earnings stood at $3.0 million in 2022, then increased by 23.86% to $3.8 million in 2023, then tumbled by 13704.68% to -$511.4 million in 2024, then soared by 100.52% to $2.6 million in 2025, then advanced by 15.45% to $3.1 million in 2026.
• The last three Retained Earnings figures came in at $3.1 million (Q1 2026), $2.6 million (Q4 2025), and -$589.3 million (Q3 2025), per Business Quant data.